| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |